• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

HQ8A:GR

2.331 EUR 0.028 1.22%

As of 02:07:23 ET on 12/19/2014.

Snapshot for Lpath Inc (HQ8A)

Open: 2.332 Day's Range: 2.331 - 2.332 Volume: 0
Previous Close: 2.303 52wk Range: 1.901 - 3.708 1-Yr Rtn: -20.66%

Stock Chart for HQ8A

No chart data available.
  • HQ8A:GR 2.332
  • 1D
  • 1M
  • 1Y
2.303
Interactive HQ8A Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HQ8A

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.1300
Est. PEG Ratio -
Market Cap (M EUR) 44.94
Shares Outstanding (M) 19.28
30 Day Average Volume 28
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HQ8A

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HQ8A

Lpath, Inc. is a drug discovery company with a focus on bioactive signaling lipids as targets for treating and diagnosing human diseases.

Michael LackInterim CEOGary J G AtkinsonSenior VP/CFO/Secretary
Dario A PaggiarinoSenior VP/Chief Dev OfcrGary WoodnuttSenior VP:Research & Dev
More Company Profile & Key Executives for HQ8A

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil